Pacira BioSciences (PCRX) Return on Capital Employed: 2011-2024
Historic Return on Capital Employed for Pacira BioSciences (PCRX) over the last 14 years, with Dec 2024 value amounting to -0.06%.
- Pacira BioSciences' Return on Capital Employed rose 8.00% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 8.00%. This contributed to the annual value of -0.06% for FY2024, which is 12.00% down from last year.
- Per Pacira BioSciences' latest filing, its Return on Capital Employed stood at -0.06% for FY2024, which was down 202.13% from 0.06% recorded in FY2023.
- Pacira BioSciences' 5-year Return on Capital Employed high stood at 0.08% for FY2021, and its period low was -0.06% during FY2024.
- Over the past 3 years, Pacira BioSciences' median Return on Capital Employed value was 0.03% (recorded in 2022), while the average stood at 0.01%.
- As far as peak fluctuations go, Pacira BioSciences' Return on Capital Employed increased by 4bps in 2020, and later dropped by 12bps in 2024.
- Pacira BioSciences' Return on Capital Employed (Yearly) stood at 0.06% in 2020, then rose by 2bps to 0.08% in 2021, then dropped by 4bps to 0.03% in 2022, then rose by 2bps to 0.06% in 2023, then declined by 12bps to -0.06% in 2024.